CROSS COUNTRY HEALTHCARE INC (CCRN) — Current Report

AI-Powered SEC Filing Analysis

Latest Current Report Filed: 2026-05-07

Key Insights

Cross Country Healthcare announced Q1 2026 earnings results on May 7, 2026, indicating the company is maintaining regular reporting cadence and operational transparency with stakeholders.
The filing references a press release as Exhibit 99.1 containing detailed financial results, but the actual earnings data, guidance, and management commentary are not included in this 8-K wrapper document itself, limiting immediate insight into performance quality.
The 8-K was signed by William J. Burns, Executive Vice President & Chief Financial Officer, confirming stable financial leadership and proper authorization of SEC filings.
Filing under both Item 2.02 (Results of Operations) and Item 7.01 (Regulation FD) indicates standard earnings announcement disclosure without material non-public information being released outside normal channels.

Want the newest filings?

This analysis covers the filing from 2026-05-07. New 10-K, 10-Q and 8-K filings are analyzed the moment they are released — exclusively in the app.

Download on the App Store Open in app →

Earlier Current Report filings

Filed: 2026-05-07

Cross Country Healthcare has agreed to be acquired by KL Criss Cross Intermediate LLC for $13.25 per share in an all-cash transaction, representing a complete change of control and exit from public markets following Nasdaq delisting.
The merger is not subject to a financing condition, reducing execution risk, though it remains contingent on stockholder approval, regulatory clearance under HSR Act, and absence of material adverse effects on the company.
All restricted stock awards with service-based vesting will be fully accelerated and converted to cash at closing, while performance-based awards will be vested at the greater of target or actual performance levels, providing full payouts to equity holders.
The company has committed to a potential sale of its locums business division to a Parent affiliate as a separate transaction, which requires separate HSR and antitrust approval, indicating potential strategic restructuring post-acquisition.

Filed: 2026-04-17

Cross Country Healthcare, Inc. filed an 8-K form on April 17, 2026, providing updates on the company's operations.
The filing does not indicate any material changes to the company's business or financial condition.
Investors should continue to monitor the company's future filings for any significant developments that could impact the stock price.

Filed: 2026-03-30

Cross Country Healthcare has appointed Amiee Hawkins as the new Chief Operating Officer, effective March 28, 2026. Hawkins has been with the company since 2014 and has held various senior leadership roles, which suggests continuity and internal promotion.
The filing does not indicate any changes to Hawkins' compensation or the existence of a new agreement, which implies the transition to COO is a natural progression within the company.
There are no related party transactions or family relationships disclosed, suggesting the appointment is a standard organizational change.

Filed: 2026-03-17

Cross Country Healthcare announced the departure of its Chief Information Officer, Phil Noe, and the associated severance and consulting agreements.
The company will pay Noe $205,975 in severance over six months and $198.04 per hour for consulting services through May 2026.
The filing provides transparency around the leadership change and associated financial implications for the company.

Filed: 2026-03-10

Cross Country Healthcare has appointed a new Senior Vice President and Chief Accounting Officer, Marvin Veizaga, effective March 10, 2026, replacing the previous officer.
The company has also announced the departure of the Chief Information Officer, Phil Noe, on the same date, with no indication of a dispute or disagreement.
The company has entered into a new letter agreement with the incoming Chief Accounting Officer, providing details on his increased base salary, annual short-term incentive bonus, and long-term incentive equity awards.

Filed: 2026-03-04

Cross Country Healthcare reported Q4 2025 results, with revenue and earnings growth compared to the prior year period.
The company maintained its positive momentum, with strong performance across its healthcare staffing and workforce solutions business lines.
Management provided an optimistic outlook for 2026, highlighting continued demand for healthcare talent and opportunities for further growth and market share gains.

Filed: 2026-02-23

Cross Country Healthcare, Inc. filed an 8-K form on February 23, 2026, providing a press release update to the market.
The company did not disclose any material news or events that would significantly impact its operations or financial performance.
Without additional details in the 8-K filing, investors may need to wait for the next scheduled earnings report to get a more comprehensive update on the company's business and outlook.

Filed: 2026-02-12

Cross Country Healthcare, Inc. filed an 8-K report on February 12, 2026, providing a press release as an exhibit. The filing does not indicate any material business updates or events.
The company's stock ticker is CCRN and it trades on the Nasdaq Stock Market.
No additional financial or operational details were provided in the 8-K filing.

Filed: 2026-01-29

Cross Country Healthcare, Inc. has scheduled its 2026 Annual Meeting of Stockholders for May 11, 2026, which is more than 30 days earlier than the previous year's meeting.
The company has provided revised deadlines for stockholder proposals and nominations to be included in the proxy statement, with the proposal deadline set for March 11, 2026 and the nomination deadline set for February 10, 2026.
Stockholders who intend to solicit proxies in support of director nominees other than the company's nominees must provide notice by March 12, 2026 to comply with the universal proxy rules.

Other reports for CROSS COUNTRY HEALTHCARE INC

Quarterly Report Insider Trading Annual Report

Important Information

AI-generated analysis is for informational purposes only. Always read original SEC filings and consult with qualified professionals before making investment decisions.